A tiny phase 1 clinical trial suggests that repeated doses of the 80-year-old BCG tuberculosis vaccine may halt the abnormal immune responses behind type 1 diabetes, allowing insulin-producing cells to regenerate.
For Those Who Want To Know….
A tiny phase 1 clinical trial suggests that repeated doses of the 80-year-old BCG tuberculosis vaccine may halt the abnormal immune responses behind type 1 diabetes, allowing insulin-producing cells to regenerate.
Posted in Health.
By Bob – August 12, 2012
For Those Who Need To Know…. New Articles and News daily. Subscribe below to have our feed sent to your email.
Proudly powered by WordPress and Carrington.
0 Responses
Stay in touch with the conversation, subscribe to the RSS feed for comments on this post.
You must be logged in to post a comment.